NAP
ACH

New Amsterdam Partners’s Accendra Health ACH Stock Holding History

New Amsterdam Partners’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-70,997
Closed -$1.34M – 128
2017
Q4 		$1.34M Buy
70,997
+4,628
+7% +$103K 0.27% 78
2017
Q3 		$1.94M Buy
+66,369
New +$1.96M 0.4% 77

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

New Amsterdam Partners's ACH Position: Q1 2018 in Review

New Amsterdam Partners sold out of Accendra Health (ACH) in Q1 2018, closing a stake of 70,997 shares — an estimated $1.34M sold.

New Amsterdam Partners first reported a position in ACH in Q3 2017 and held it in 2 quarters. The position peaked at $1.94M in Q3 2017. 242 funds tracked by Wall St. Rank hold ACH as of Q1 2018.

  • New Amsterdam Partners reported no remaining Accendra Health position as of Q1 2018 after selling out during the quarter.
  • New Amsterdam Partners sold 70,997 Accendra Health shares in Q1 2018, an estimated $1.34M.
  • New Amsterdam Partners first reported a position in Accendra Health in Q3 2017 and held it in 2 quarters.
  • New Amsterdam Partners's Accendra Health position peaked at $1.94M in Q3 2017.
  • 242 funds tracked by Wall St. Rank held Accendra Health as of Q1 2018.

Based on New Amsterdam Partners's 13F filing for Q1 2018, filed 7 May 2018.